TABLE 2.
Biomarkers Assessed in NordiQC 2017-2021
| General Module | Breast Module | Companion Module | ||
|---|---|---|---|---|
| ALK-LUNG (2) | CEA | OCT3/4 | ER (10) | PD-L1 TPS/CPS (10) |
| AMACR | CGA | p16 | HER2 (10) | PD-L1 IC score (5) |
| ASMA (2) | CK19 | p40 | PR (5) | — |
| Bcl2 | CK20 | p53 | — | — |
| Bcl6 | CK5 (2) | p63 | — | — |
| BRAF | CK7 | PAX8 (4) | — | — |
| BSAP | CK-LMW (2) | PMS2 (2) | — | — |
| CD10 | CK-PAN (2) | Podop | — | — |
| CD117 (2) | CMYC | S100 (2) | — | — |
| CD15 | CR | S100 | — | — |
| CD23 | ECAD | SATB2 | — | — |
| CD30 | EPCAM | SMAD4 | — | — |
| CD31 (2) | ERG | SMH | — | — |
| CD45 | GATA3 (2) | SOX10 (2) | — | — |
| CD5 | MLA (3) | SYP | — | — |
| CD56 | MLH1 (2) | TdT | — | — |
| CD68 | MSH2 (2) | TTF1 | — | — |
| CD79a | MSH6 (2) | UP | — | — |
| CD8 | MUM1 | VIM | — | — |
| CDX2 | NKX3.1 (2) | WT1 | — | — |
Number in brackets indicate number of repeats.
TPS/CPS indicates tumor proportion score/combines positive score.